Prognostic Significance of FDG-PET/CT on Determining Upfront Autologous Stem Cell Transplantation for the Treatment of Peripheral T Cell Lymphomas

MLA

Ahn, Seo-Yeon, et al. “Prognostic Significance of FDG-PET/CT on Determining Upfront Autologous Stem Cell Transplantation for the Treatment of Peripheral T Cell Lymphomas.” Blood, vol. 132, no. 1, Number 1 Supplement 1, Nov. 2018, p. 1632. EBSCOhost, https://doi.org/10.1182/blood-2018-99-118168.

APA

Ahn, S.-Y., Jung, S.-Y., Jung, S.-H., Ahn, J.-S., Lee, J.-J., Kim, H.-J., Kang, S.-R., Han, Y.-H., Kwak, J.-Y., Yhim, H.-Y., & Yang, D.-H. (2018). Prognostic Significance of FDG-PET/CT on Determining Upfront Autologous Stem Cell Transplantation for the Treatment of Peripheral T Cell Lymphomas. Blood, 132(1, Number 1 Supplement 1), 1632. https://doi.org/10.1182/blood-2018-99-118168

Chicago

Ahn, Seo-Yeon, Seung-Yeon Jung, Sung-Hoon Jung, Jae-Sook Ahn, Je-Jung Lee, Hyeoung-Joon Kim, Sae-Ryung Kang, et al. 2018. “Prognostic Significance of FDG-PET/CT on Determining Upfront Autologous Stem Cell Transplantation for the Treatment of Peripheral T Cell Lymphomas.” Blood 132 (1, Number 1 Supplement 1): 1632. doi:10.1182/blood-2018-99-118168.